Clinical Trials Directory

Trials / Unknown

UnknownNCT06192446

Factors Influencing Adherence to Adjuvant Endocrine Therapy

Factors Influencing Adherence to Adjuvant Endocrine Therapy in Women With Early Breast Cancer in Croatia

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
University of Zagreb · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

Breast cancer is the most common type of cancer and the leading cause of cancer death in women. Adjuvant endocrine therapy (AET) reduces the risk of disease recurrence and mortality in women with hormone-dependent breast cancer. This cross-sectional study aims to investigate adherence to AET and identify factors associated with adherence in the Republic of Croatia. The level of adherence, beliefs about medicines, and quality of life with AET will be investigated with validated instruments in the form of an anonymous survey. Given the available data on suboptimal adherence to AET in Europe and globally, it is clear that there is a need for investigating adherence in Croatia which hasn't been done so far. Each country, population, and health system has its own characteristics, and understanding the experience of using AET and identifying associated psychosocial factors could help in developing specific interventions supporting women and improving AET adherence.

Conditions

Interventions

TypeNameDescription
DRUGSurvey using a questionnaire.An observational study conducted in a cross-sectional manner using a questionnaire.

Timeline

Start date
2021-09-20
Primary completion
2024-09-20
Completion
2024-09-20
First posted
2024-01-05
Last updated
2024-01-11

Locations

1 site across 1 country: Croatia

Regulatory

Source: ClinicalTrials.gov record NCT06192446. Inclusion in this directory is not an endorsement.